
Bacteriophage Industry Research Report 2025
Description
Summary
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
According to APO Research, The global Bacteriophage market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and Pherecydes Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage.
The Bacteriophage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Bacteriophage Segment by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Bacteriophage Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacteriophage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacteriophage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacteriophage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bacteriophage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture.
According to APO Research, The global Bacteriophage market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Bacteriophage is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Bacteriophage include NPO Microgen, Proteon Pharmaceuticals, Phagelux, Intralytix, Micreos, Eliava BioPreparations, Locus Biosciences,Inc, Pharmex Group,LLC and Pherecydes Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bacteriophage, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bacteriophage.
The Bacteriophage market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bacteriophage market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Bacteriophage Segment by Company
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Bacteriophage Segment by Type
DsDNA Bacteriophage
SsDNA Bacteriophage
SsRNA Bacteriophage
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Application
Animal Health
Aquaculture
Agriculture
Food Industry
Human Health
Others
Bacteriophage Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bacteriophage market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bacteriophage and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bacteriophage.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Bacteriophage companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
120 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Bacteriophage by Type
- 2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
- 2.2.2 DsDNA Bacteriophage
- 2.2.3 SsDNA Bacteriophage
- 2.2.4 SsRNA Bacteriophage
- 2.2.5 Others
- 2.3 Bacteriophage by Application
- 2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.3.2 Animal Health
- 2.3.3 Aquaculture
- 2.3.4 Agriculture
- 2.3.5 Food Industry
- 2.3.6 Human Health
- 2.3.7 Others
- 2.4 Assumptions and Limitations
- 3 Bacteriophage Breakdown Data by Type
- 3.1 Global Bacteriophage Historic Market Size by Type (2020-2025)
- 3.2 Global Bacteriophage Forecasted Market Size by Type (2026-2031)
- 4 Bacteriophage Breakdown Data by Application
- 4.1 Global Bacteriophage Historic Market Size by Application (2020-2025)
- 4.2 Global Bacteriophage Forecasted Market Size by Application (2026-2031)
- 5 Global Growth Trends
- 5.1 Global Bacteriophage Market Perspective (2020-2031)
- 5.2 Global Bacteriophage Growth Trends by Region
- 5.2.1 Global Bacteriophage Market Size by Region: 2020 VS 2024 VS 2031
- 5.2.2 Bacteriophage Historic Market Size by Region (2020-2025)
- 5.2.3 Bacteriophage Forecasted Market Size by Region (2026-2031)
- 5.3 Bacteriophage Market Dynamics
- 5.3.1 Bacteriophage Industry Trends
- 5.3.2 Bacteriophage Market Drivers
- 5.3.3 Bacteriophage Market Challenges
- 5.3.4 Bacteriophage Market Restraints
- 6 Market Competitive Landscape by Players
- 6.1 Global Top Bacteriophage Players by Revenue
- 6.1.1 Global Top Bacteriophage Players by Revenue (2020-2025)
- 6.1.2 Global Bacteriophage Revenue Market Share by Players (2020-2025)
- 6.2 Global Bacteriophage Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Bacteriophage Head Office and Area Served
- 6.4 Global Bacteriophage Players, Product Type & Application
- 6.5 Global Bacteriophage Manufacturers Established Date
- 6.6 Global Bacteriophage Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
- 7 North America
- 7.1 North America Bacteriophage Market Size (2020-2031)
- 7.2 North America Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 7.3 North America Bacteriophage Market Size by Country (2020-2025)
- 7.4 North America Bacteriophage Market Size by Country (2026-2031)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
- 8 Europe
- 8.1 Europe Bacteriophage Market Size (2020-2031)
- 8.2 Europe Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 8.3 Europe Bacteriophage Market Size by Country (2020-2025)
- 8.4 Europe Bacteriophage Market Size by Country (2026-2031)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
- 9 Asia-Pacific
- 9.1 Asia-Pacific Bacteriophage Market Size (2020-2031)
- 9.2 Asia-Pacific Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 9.3 Asia-Pacific Bacteriophage Market Size by Country (2020-2025)
- 9.4 Asia-Pacific Bacteriophage Market Size by Country (2026-2031)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
- 10 South America
- 10.1 South America Bacteriophage Market Size (2020-2031)
- 10.2 South America Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 10.3 South America Bacteriophage Market Size by Country (2020-2025)
- 10.4 South America Bacteriophage Market Size by Country (2026-2031)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
- 11 Middle East & Africa
- 11.1 Middle East & Africa Bacteriophage Market Size (2020-2031)
- 11.2 Middle East & Africa Bacteriophage Market Growth Rate by Country: 2020 VS 2024 VS 2031
- 11.3 Middle East & Africa Bacteriophage Market Size by Country (2020-2025)
- 11.4 Middle East & Africa Bacteriophage Market Size by Country (2026-2031)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
- 12 Players Profiled
- 12.1 NPO Microgen
- 12.1.1 NPO Microgen Company Information
- 12.1.2 NPO Microgen Business Overview
- 12.1.3 NPO Microgen Revenue in Bacteriophage Business (2020-2025)
- 12.1.4 NPO Microgen Bacteriophage Product Portfolio
- 12.1.5 NPO Microgen Recent Developments
- 12.2 Proteon Pharmaceuticals
- 12.2.1 Proteon Pharmaceuticals Company Information
- 12.2.2 Proteon Pharmaceuticals Business Overview
- 12.2.3 Proteon Pharmaceuticals Revenue in Bacteriophage Business (2020-2025)
- 12.2.4 Proteon Pharmaceuticals Bacteriophage Product Portfolio
- 12.2.5 Proteon Pharmaceuticals Recent Developments
- 12.3 Phagelux
- 12.3.1 Phagelux Company Information
- 12.3.2 Phagelux Business Overview
- 12.3.3 Phagelux Revenue in Bacteriophage Business (2020-2025)
- 12.3.4 Phagelux Bacteriophage Product Portfolio
- 12.3.5 Phagelux Recent Developments
- 12.4 Intralytix
- 12.4.1 Intralytix Company Information
- 12.4.2 Intralytix Business Overview
- 12.4.3 Intralytix Revenue in Bacteriophage Business (2020-2025)
- 12.4.4 Intralytix Bacteriophage Product Portfolio
- 12.4.5 Intralytix Recent Developments
- 12.5 Micreos
- 12.5.1 Micreos Company Information
- 12.5.2 Micreos Business Overview
- 12.5.3 Micreos Revenue in Bacteriophage Business (2020-2025)
- 12.5.4 Micreos Bacteriophage Product Portfolio
- 12.5.5 Micreos Recent Developments
- 12.6 Eliava BioPreparations
- 12.6.1 Eliava BioPreparations Company Information
- 12.6.2 Eliava BioPreparations Business Overview
- 12.6.3 Eliava BioPreparations Revenue in Bacteriophage Business (2020-2025)
- 12.6.4 Eliava BioPreparations Bacteriophage Product Portfolio
- 12.6.5 Eliava BioPreparations Recent Developments
- 12.7 Locus Biosciences,Inc
- 12.7.1 Locus Biosciences,Inc Company Information
- 12.7.2 Locus Biosciences,Inc Business Overview
- 12.7.3 Locus Biosciences,Inc Revenue in Bacteriophage Business (2020-2025)
- 12.7.4 Locus Biosciences,Inc Bacteriophage Product Portfolio
- 12.7.5 Locus Biosciences,Inc Recent Developments
- 12.8 Pharmex Group,LLC
- 12.8.1 Pharmex Group,LLC Company Information
- 12.8.2 Pharmex Group,LLC Business Overview
- 12.8.3 Pharmex Group,LLC Revenue in Bacteriophage Business (2020-2025)
- 12.8.4 Pharmex Group,LLC Bacteriophage Product Portfolio
- 12.8.5 Pharmex Group,LLC Recent Developments
- 12.9 Pherecydes Pharma
- 12.9.1 Pherecydes Pharma Company Information
- 12.9.2 Pherecydes Pharma Business Overview
- 12.9.3 Pherecydes Pharma Revenue in Bacteriophage Business (2020-2025)
- 12.9.4 Pherecydes Pharma Bacteriophage Product Portfolio
- 12.9.5 Pherecydes Pharma Recent Developments
- 12.10 APS Biocontrol Ltd. (APS)
- 12.10.1 APS Biocontrol Ltd. (APS) Company Information
- 12.10.2 APS Biocontrol Ltd. (APS) Business Overview
- 12.10.3 APS Biocontrol Ltd. (APS) Revenue in Bacteriophage Business (2020-2025)
- 12.10.4 APS Biocontrol Ltd. (APS) Bacteriophage Product Portfolio
- 12.10.5 APS Biocontrol Ltd. (APS) Recent Developments
- 12.11 Qingdao Phagepharm Bio-tech
- 12.11.1 Qingdao Phagepharm Bio-tech Company Information
- 12.11.2 Qingdao Phagepharm Bio-tech Business Overview
- 12.11.3 Qingdao Phagepharm Bio-tech Revenue in Bacteriophage Business (2020-2025)
- 12.11.4 Qingdao Phagepharm Bio-tech Bacteriophage Product Portfolio
- 12.11.5 Qingdao Phagepharm Bio-tech Recent Developments
- 12.12 Fixed-Phage Limited
- 12.12.1 Fixed-Phage Limited Company Information
- 12.12.2 Fixed-Phage Limited Business Overview
- 12.12.3 Fixed-Phage Limited Revenue in Bacteriophage Business (2020-2025)
- 12.12.4 Fixed-Phage Limited Bacteriophage Product Portfolio
- 12.12.5 Fixed-Phage Limited Recent Developments
- 12.13 Zeptometrix
- 12.13.1 Zeptometrix Company Information
- 12.13.2 Zeptometrix Business Overview
- 12.13.3 Zeptometrix Revenue in Bacteriophage Business (2020-2025)
- 12.13.4 Zeptometrix Bacteriophage Product Portfolio
- 12.13.5 Zeptometrix Recent Developments
- 12.14 Phage International, Inc.
- 12.14.1 Phage International, Inc. Company Information
- 12.14.2 Phage International, Inc. Business Overview
- 12.14.3 Phage International, Inc. Revenue in Bacteriophage Business (2020-2025)
- 12.14.4 Phage International, Inc. Bacteriophage Product Portfolio
- 12.14.5 Phage International, Inc. Recent Developments
- 12.15 MicroMir
- 12.15.1 MicroMir Company Information
- 12.15.2 MicroMir Business Overview
- 12.15.3 MicroMir Revenue in Bacteriophage Business (2020-2025)
- 12.15.4 MicroMir Bacteriophage Product Portfolio
- 12.15.5 MicroMir Recent Developments
- 12.16 iNtODEWORLD, Inc.
- 12.16.1 iNtODEWORLD, Inc. Company Information
- 12.16.2 iNtODEWORLD, Inc. Business Overview
- 12.16.3 iNtODEWORLD, Inc. Revenue in Bacteriophage Business (2020-2025)
- 12.16.4 iNtODEWORLD, Inc. Bacteriophage Product Portfolio
- 12.16.5 iNtODEWORLD, Inc. Recent Developments
- 12.17 NEXTBIOTICS
- 12.17.1 NEXTBIOTICS Company Information
- 12.17.2 NEXTBIOTICS Business Overview
- 12.17.3 NEXTBIOTICS Revenue in Bacteriophage Business (2020-2025)
- 12.17.4 NEXTBIOTICS Bacteriophage Product Portfolio
- 12.17.5 NEXTBIOTICS Recent Developments
- 12.18 Armata Pharmaceuticals, Inc.
- 12.18.1 Armata Pharmaceuticals, Inc. Company Information
- 12.18.2 Armata Pharmaceuticals, Inc. Business Overview
- 12.18.3 Armata Pharmaceuticals, Inc. Revenue in Bacteriophage Business (2020-2025)
- 12.18.4 Armata Pharmaceuticals, Inc. Bacteriophage Product Portfolio
- 12.18.5 Armata Pharmaceuticals, Inc. Recent Developments
- 12.19 Innophage
- 12.19.1 Innophage Company Information
- 12.19.2 Innophage Business Overview
- 12.19.3 Innophage Revenue in Bacteriophage Business (2020-2025)
- 12.19.4 Innophage Bacteriophage Product Portfolio
- 12.19.5 Innophage Recent Developments
- 12.20 Adaptive Phage Therapeutics
- 12.20.1 Adaptive Phage Therapeutics Company Information
- 12.20.2 Adaptive Phage Therapeutics Business Overview
- 12.20.3 Adaptive Phage Therapeutics Revenue in Bacteriophage Business (2020-2025)
- 12.20.4 Adaptive Phage Therapeutics Bacteriophage Product Portfolio
- 12.20.5 Adaptive Phage Therapeutics Recent Developments
- 12.21 TechnoPhage
- 12.21.1 TechnoPhage Company Information
- 12.21.2 TechnoPhage Business Overview
- 12.21.3 TechnoPhage Revenue in Bacteriophage Business (2020-2025)
- 12.21.4 TechnoPhage Bacteriophage Product Portfolio
- 12.21.5 TechnoPhage Recent Developments
- 13 Report Conclusion
- 14 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.